Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001908192 | SCV002148341 | pathogenic | Frontotemporal dementia and/or amyotrophic lateral sclerosis 1; Paget disease of bone 2, early-onset | 2021-11-03 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Studies have shown that disruption of this splice site results in skipping of exon 2, but is expected to preserve the integrity of the reading-frame (PMID: 29959261). Disruption of this splice site has been observed in individuals with neurodegeneration with ataxia, dystonia, and gaze palsy (PMID: 29959261, 30638816). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 2 of the SQSTM1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. |